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The title compound, C 10 H 7 F 3 N 2 O, is an analogue of pyrazolone derivatives with potential analgesic and anti-inflammatory properties. Its molecular structure consists of phenyl and pyrazol-3(2H)-one units with a dihedral angle between the mean planes of the rings of 33.0 (1) . The crystal structure is stabilized by an intermolecular hydrogen bond between the N-H group and the carbonyl O atom of the pyrazol-3(2H)one ring which links the molecules into supramolecular C(5) chains along [001] and by weakstacking interactions between the phenyl rings [centroid-centroid distance = 3.881 (2) Å ]. The F atoms are disordered over two positions with refined site occupancies of 0.768(11) and 0.232(11).
Related literature
For the analgesic properties of pyrazolones, see: Mehlisch (1983) ; Schnitzer (2003) . For the biological activity of some pyrazolone derivatives, see: Pavlov et al. (1998) . For the pharmacological properties of pyrazolone deriavtives, see: Kees et al. (1996) . For related structures, see: Belmar et al. (2006a,b); Pé rez et al. (2005) . For metal complexes, see: Hyun-Shin et al. (2008) ; Gallardo et al. (2004) ; Meyer et al. (1998) . For the synthesis of pyrazolones, see: Nakagawa et al. (2006) ; Belmar et al. (2001) ; Bartulín et al. (1994) . For hydrogen-bond motifs, see: Bernstein et al. (1995) . Table 1 Hydrogen-bond geometry (Å , ).
Experimental
Symmetry code: (i) x; Ày þ 3 2 ; z À 1 2 .
Data collection: CAD-4 Software (Enraf-Nonius, 1989); cell refinement: SET4 in CAD-4 Software; data reduction: HELENA (Spek, 1996) ; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: PLATON (Spek, 2009); software used to prepare material for publication: SHELXL97. 
Comment
The pyrazolone analgesics (such as phenylbutazone) have effects similar to those of aspirin. They were commonly used to treat rheumatoid arthritis and has been the focus of medicinal chemists for over last 100 years because of the outstanding pharmacological properties shown by several of its derivatives (Kees et al., 1996) . The interest in such compounds, pyrazolone derivative, arises from the fact that the incorporation of heteroatoms can result an ancillary ligand to study their photoactive lanthanide complexes. These compounds possess several sites for substitution, allowing for a systematic analysis of their effects on the photo optical properties. Particulary the luminescence properties of the Eu and Tb complexes.
The molecular structure of (I) consists of a phenyl group bonded to 2-N of the dihydropyrazole heterocyclic ring (Fig. 1 ).
These rings are twisted with respect to each other and the dihedral angle between the mean plane is 33.0 (1)°.The molecules are linked into chains by one intermolecular N-H···O hydrogen bond. Atoms N2 in the molecules at (x,y,z) acts as hydrogen bonds donor vía atom H2 to atoms O1 at (-x, 3/2+y, -1-z) so generating by translation one C(5) chains running parallel to
[001] direction (Bernstein et al., 1995) , (Fig. 2, Table 1 ) and the crystal structure is reinforced by a weak face-to-face π-π stacking interactions between phenyl rings with the centroid-centroid distance of 3.881 (2) Å.
Refinement
All non-H atoms were refined with anisotropic displacement parameters. H Ar atoms were placed at their idealized positions with distances of 0.93 Å and U eq fixed at 1.2 U iso of the preceding atom. H atom attached to N atom was located from Fourier difference map and treated with riding model. Fluorine atoms are disordered over two alternative positions with refined site occupancies of 0.768 (11) and 0.232 (11). Fig. 1 . The molecular structure of (I) with labeling scheme. Displacement ellipsoids are shown at the 40% probability level. 
Figures

Special details
Experimental. The title compound was synthesized by the condensation of ethyl 4,4,4-trifluoroacetoacetate (5.0?g, 27.2?mmol) in acetic acid (50?ml) with phenylhydrazine (2.9?g, 27.2?mmol) which was added drop wise, with stirring for 3?h. The solvent was removed by evaporation; resulting crude solid was extracted with AcOEt. The organic layer was washed with saturated aqueous NaHCO3 and water, then brine, and evaporation the solvent. The compound, obtained as colorless single crystals, was recrystallized using ethylacetate and n-hexane (2:1) and was suitable for X-ray structure determination. Yield 76% mp: 191-192 °C, lit. 195-196 °C (Nakagawa et al., 2006) . 400?MHz, d, p.p.m.) 12, 42 (1H, s), 7, 70 (2H, d, J = 8?Hz), 7, 49 (2H, t, J = 8?Hz), 7, 36 (1H, t, J = 8?Hz), 5, 92 (1H, s) . 400?MHz, d, p.p.m.) 
